Abstract: |
Invariant natural killer T (iNKT) cells are a special subset of αβ T cells with invariant TCR, which recognize α-galactosylceramide (α-GalCer) presented by CD1d. In addition to signals through the invariant TCR upon stimulation with α-GalCer, costimulatory signals, such as signals through CD28 and OX40, are indispensable for full activation of iNKT cells. In this study, we investigated the functions of a well-known costimulatory molecule, glucocorticoid-induced TNF receptor (GITR), on Ag-induced iNKT cell activation. Unexpectedly, engagement of GITR by agonistic mAb DTA-1 suppressed proliferation and cytokine production of iNKT cells upon α-GalCer stimulation. In addition, GITR signals in iNKT cells during only the Ag-priming phase was sufficient to inhibit the iNKT cell activation. Consistent with these results, the GITR-deficient iNKT cells showed enhanced proliferation and increased cytokine production upon α-GalCer stimulation both in vitro and in vivo. Furthermore, the in vivo administration of a-GalCer suppressed tumor metastasis more efficiently in GITR-deficient mice than in wild-type mice. Collectively, GITR plays a co-inhibitory role in Ag-induced iNKT cell activation. © 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. |
Keywords: |
signal transduction; controlled study; unclassified drug; nonhuman; protein function; lymphocyte proliferation; animal cell; mouse; animal; animals; mice; animal experiment; animal model; in vivo study; cytotoxicity; in vitro study; wild type; mice, inbred c57bl; physiology; immunoregulation; c57bl mouse; monoclonal antibody; cancer inhibition; cytokine; immunology; lymphocyte activation; glucocorticoid; natural killer cell; killer cells, natural; cytokine production; cytotoxicity, immunologic; tumor necrosis factor receptor; protein deficiency; immunostimulation; glucocorticoid induced tumor necrosis factor receptor; protein determination; t lymphocyte activation; glucocorticoid induced tumor necrosis factor receptor antibody; glucocorticoids; alpha galactosylceramide; cd1d antigen; natural killer t cell; receptors, tumor necrosis factor; galactosylceramide; cd1 antigen; antigens, cd1; co-inhibitory signal; glucocorticoid-induced tnf receptor; invariant nkt cell; alpha-galactosylceramide; galactosylceramides
|